IGM Biosciences Statistics
Total Valuation
IGMS has a market cap or net worth of $435.61 million. The enterprise value is $137.85 million.
| Market Cap | 435.61M |
| Enterprise Value | 137.85M |
Important Dates
The next estimated earnings date is Friday, May 10, 2024, before market open.
| Earnings Date | May 10, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
IGMS has 58.79 million shares outstanding. The number of shares has increased by 25.92% in one year.
| Shares Outstanding | 58.79M |
| Shares Change (YoY) | +25.92% |
| Shares Change (QoQ) | +0.56% |
| Owned by Insiders (%) | 35.23% |
| Owned by Institutions (%) | 68.10% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 204.51 |
| Forward PS | 133.33 |
| PB Ratio | 2.14 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 64.72 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.18, with a Debt / Equity ratio of 0.20.
| Current Ratio | 8.18 |
| Quick Ratio | n/a |
| Debt / Equity | 0.20 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -103.20% and return on invested capital (ROIC) is -108.09%.
| Return on Equity (ROE) | -103.20% |
| Return on Assets (ROA) | -53.50% |
| Return on Capital (ROIC) | -108.09% |
| Revenue Per Employee | $9,509 |
| Profits Per Employee | -$1.10M |
| Employee Count | 224 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, IGMS has paid $678,000 in taxes.
| Income Tax | 678,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -30.09% in the last 52 weeks. The beta is 0.25, so IGMS's price volatility has been lower than the market average.
| Beta (1Y) | 0.25 |
| 52-Week Price Change | -30.09% |
| 50-Day Moving Average | 11.26 |
| 200-Day Moving Average | 8.60 |
| Relative Strength Index (RSI) | 32.57 |
| Average Volume (30 Days) | 257,961 |
Short Selling Information
The latest short interest is 5.22 million, so 8.88% of the outstanding shares have been sold short.
| Short Interest | 5.22M |
| Short Previous Month | 4.76M |
| Short % of Shares Out | 8.88% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 20.23 |
Income Statement
In the last 12 months, IGMS had revenue of $2.13 million and -$246.42 million in losses. Loss per share was -$4.71.
| Revenue | 2.13M |
| Gross Profit | 2.13M |
| Operating Income | -263.46M |
| Pretax Income | -245.74M |
| Net Income | -246.42M |
| EBITDA | -232.05M |
| EBIT | -245.74M |
| Loss Per Share | -$4.71 |
Balance Sheet
The company has $338.27 million in cash and $40.51 million in debt, giving a net cash position of $297.76 million or $5.07 per share.
| Cash & Cash Equivalents | 338.27M |
| Total Debt | 40.51M |
| Net Cash | 297.76M |
| Net Cash Per Share | $5.07 |
| Equity / Book Value | 203.23M |
| Book Value Per Share | 3.46 |
| Working Capital | 305.12M |
Cash Flow
In the last 12 months, operating cash flow was -$192.23 million and capital expenditures -$12.38 million, giving a free cash flow of -$204.61 million.
| Operating Cash Flow | -192.23M |
| Capital Expenditures | -12.38M |
| Free Cash Flow | -204.61M |
| FCF Per Share | -$3.91 |
Margins
Gross margin is 100.00%, with operating and profit margins of -12,369.06% and -11,568.83%.
| Gross Margin | 100.00% |
| Operating Margin | -12,369.06% |
| Pretax Margin | -11,537.00% |
| Profit Margin | -11,568.83% |
| EBITDA Margin | -10,894.23% |
| EBIT Margin | -11,537.00% |
| FCF Margin | -9,606.20% |
Dividends & Yields
IGMS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -25.92% |
| Shareholder Yield | -25.92% |
| Earnings Yield | -56.57% |
| FCF Yield | -46.97% |
Analyst Forecast
The average price target for IGMS is $17.25, which is 132.79% higher than the current price. The consensus rating is "Buy".
| Price Target | $17.25 |
| Price Target Difference | 132.79% |
| Analyst Consensus | Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | 178.86% |
| EPS Growth Forecast (5Y) | -18.11% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
IGMS has an Altman Z-Score of -2.57 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.57 |
| Piotroski F-Score | 3 |